Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 4206206)

Published in Int J Chron Obstruct Pulmon Dis on October 14, 2014

Authors

Shambhu Aryal1, Enrique Diaz-Guzman2, David M Mannino3

Author Affiliations

1: Division of Pulmonary, Allergy and Critical Care Medicine, Duke University, Durham, NC, USA.
2: Division of Pulmonary, Allergy and Critical Care, University of Alabama, Birmingham, AL, USA.
3: Department of Preventive Medicine and Environmental Health, University of Kentucky, Lexington, KY, USA.

Articles citing this

Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension. Int J Chron Obstruct Pulmon Dis (2015) 0.81

Disability-Free Life Expectancy Over 30 Years: A Growing Female Disadvantage in the US Population. Am J Public Health (2016) 0.80

Women and Lung Disease. Sex Differences and Global Health Disparities. Am J Respir Crit Care Med (2015) 0.78

Depression diagnosed by the mini international neuropsychiatric interview plus (MINI) in patients with chronic obstructive pulmonary disease: relationship with functional capacity and quality of life. BMC Res Notes (2016) 0.78

Diagnosing COPD: advances in training and practice - a systematic review. Adv Med Educ Pract (2016) 0.78

Analysis of pulmonary function test results in a health check-up population. J Thorac Dis (2015) 0.77

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit. PLoS One (2015) 0.76

In reply. Dtsch Arztebl Int (2015) 0.75

GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respir Res (2017) 0.75

COPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study. PLoS One (2016) 0.75

Mortality from asbestos-associated disease in Libby, Montana 1979-2011. J Expo Sci Environ Epidemiol (2016) 0.75

Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases. Sci Rep (2017) 0.75

The Prevalence of Chronic Obstructive Pulmonary Disease and the Determinants of Underdiagnosis in Women Exposed to Biomass Fuel in India- a Cross Section Study. Chonnam Med J (2016) 0.75

Articles cited by this

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03

Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66

50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07

Deaths: final data for 2010. Natl Vital Stat Rep (2013) 5.95

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (2005) 5.61

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care (2001) 5.61

Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med (2007) 4.82

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92

Gender differences in airway behaviour over the human life span. Thorax (1999) 3.52

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J (2004) 3.19

Gender bias in the diagnosis of COPD. Chest (2001) 2.87

Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80

Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77

In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med (2003) 2.64

Gender and COPD in patients attending a pulmonary clinic. Chest (2005) 2.59

Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis. Thorax (2013) 2.52

Women and tobacco. Respirology (2003) 2.51

Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51

Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med (2010) 2.43

The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med (1987) 2.43

Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med (2006) 2.28

Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20

Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med (2005) 2.20

Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med (2011) 2.06

Sex differences in the incidence and severity of respiratory tract infections. Respir Med (2007) 1.99

Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med (2002) 1.87

Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax (2010) 1.82

Asthma as a risk factor for COPD in a longitudinal study. Chest (2004) 1.82

Sex differences in mortality in patients with COPD. Eur Respir J (2008) 1.79

Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73

Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.72

Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology (2006) 1.50

Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol (2013) 1.47

Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44

Asthma, the sex difference. Curr Opin Pulm Med (2011) 1.39

Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med (2004) 1.37

COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest (2007) 1.35

Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J (2006) 1.34

Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med (2010) 1.33

COPD in India: Iceberg or volcano? J Thorac Dis (2012) 1.30

Prescription bias and factors associated with improper use of inhalers. J Aerosol Med (2006) 1.29

Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med (2004) 1.28

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med (2002) 1.27

Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2002) 1.27

Dispelling myths about gender differences in smoking cessation: population data from the USA, Canada and Britain. Tob Control (2012) 1.23

COPD and gender differences: an update. Transl Res (2013) 1.19

Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J (2006) 1.14

Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J (2010) 1.14

Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc (2007) 1.13

Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes (2006) 1.12

Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest (2011) 1.07

Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med (2005) 1.07

Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol (2010) 1.06

Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med (2009) 1.05

Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract (2009) 1.04

Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med (2005) 0.97

Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J (2001) 0.97

Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest (2001) 0.92

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med (2004) 0.92

[Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol (2006) 0.91

Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2012) 0.89

Occupational chronic obstructive pulmonary disease: an update. Clin Chest Med (2012) 0.88

Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Prim Care Respir J (2004) 0.88

Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt) (2012) 0.85

Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One (2012) 0.85

Disparities in pneumococcal and influenza immunization among older adults in Israel: a cross-sectional analysis of socio-demographic barriers to vaccination. Prev Med (2013) 0.84

Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2007) 0.83

Functional status in pulmonary rehabilitation participants. J Cardiopulm Rehabil (1999) 0.83

Associations of muscle depletion with health status. Another gender difference in COPD? Clin Nutr (2010) 0.79

Articles by these authors

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet Respir Med (2016) 0.78